The medical community is excited with anticipation surrounding retatrutide, a novel dual GIP and GLP-1 receptor that’s showing significant efficacy in clinical trials for managing obesity. Unlike some available weight loss solutions, retatrutide appears to offer a significant substantial decrease in body size and enhance metabolic markers, partic